Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Eisai reports death in phase I study of E-2082

July 31, 2019

In vivo disposition kinetics of CTI-1601

July 31, 2019

Editing modifiers, not disease gene, improves dystrophy symptoms

July 31, 2019

Microbiome metabolites modulate ALS

July 30, 2019

Alterity Therapeutics completes phase I study of PBT-434

July 30, 2019

Masitinib can slow the functional decline in ALS patients

July 30, 2019

FDA clears IND for EPX-100 for Dravet syndrome

July 29, 2019

New ketamine prodrugs presented by XW Laboratories

July 29, 2019

Phase III OPTIMUM study of ponesimod in relapsing MS meets primary endpoint

July 26, 2019

Novel pigenin derivative with anti-ischemic and neuroprotective effects following ischemia in rats

July 26, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....